Acutaas Chemicals Limited (NSE:ACUTAAS)

Market Cap	115.12B
Revenue (ttm)	10.37B
Net Income (ttm)	1.89B
Shares Out	81.87M
EPS (ttm)	23.19
PE Ratio	60.64
Forward PE	46.57
Dividend	1.50 (0.11%)
Ex-Dividend Date	n/a

Volume	3,580
Average Volume	13,446
Open	1,424.95
Previous Close	1,413.30
Day's Range	1,397.75 - 1,425.00
52-Week Range	675.60 - 1,444.05
Beta	-0.07
RSI	67.17
Earnings Date	Nov 14, 2025

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formul...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 676
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACUTAAS

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.